AI drug discovery startup Basecamp Research raises $140M

AI drug discovery startup Basecamp Research raises $140M

Basecamp Research Ltd. today announced that it has raised $140 million in funding from a group of prominent investors.

S32, a fund affiliated with Google LLC co-founder Bill Maris, led the Series C round. It was joined by more than a dozen other investors. The group included NATO, Nvidia Corp. and the Anthology Fund, a $100 million joint venture between Anthropic PBC and Menlo Ventures.

Basecamp’s flagship offering is a foundation model…